Related Experiment Video
Updated: Dec 23, 2025
05:22
Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model
Published on: October 9, 2015
12.4K
Methodology for the Isolation and Analysis of CTCs.
Clotilde Costa1,2, Ana B Dávila-Ibáñez3
1Roche-Chus Joint Unit, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain. clotilde.costa.nogueira@sergas.es.
Advances in Experimental Medicine and Biology
|April 19, 2020
Summary
Understanding circulating tumor cells (CTCs) is crucial for reducing breast cancer deaths. Current technologies for isolating CTCs lack standardization, hindering clinical use despite their diagnostic potential.
Area of Science:
- Oncology
- Biotechnology
- Cancer Research
Background:
- Breast cancer mortality is primarily driven by metastasis.
- Circulating tumor cells (CTCs) are key indicators of metastatic spread.
- Liquid biopsies, including CTC analysis, offer potential for cancer monitoring.
Purpose of the Study:
- To review and analyze current technologies for isolating circulating tumor cells (CTCs).
- To discuss the properties, selection methods (positive/negative), and clinical relevance of CTC isolation techniques, particularly for breast cancer.
- To provide a future outlook on CTC detection challenges and requirements.
Main Methods:
- Focus on CTC isolation technologies based on cell properties.
- Categorization of methods into positive and negative selection strategies.
- Evaluation of technologies for their potential clinical application in breast cancer.
Main Results:
- No single gold standard technology for CTC isolation currently exists.
- Most existing CTC isolation technologies require further validation for clinical use.
- Diverse technologies exist, varying in their effectiveness and suitability for different applications.
Conclusions:
- Standardization and validation of CTC isolation technologies are essential for clinical adoption.
- Advancements in CTC detection are critical for improving breast cancer patient outcomes.
- Further research is needed to overcome challenges in CTC analysis for reliable cancer management.
